Jared A. Olson

Jared A. Olson, PharmD, BCPPS, FPIDS

Languages spoken: English

Academic Information

Departments Primary - Pediatrics

Divisions: Infectious Diseases

Education History

Undergraduate Brigham Young University
 BA
Graduate Training Midwestern University
 PharmD
Residency Primary Children¿s Medical Center
 Resident

Selected Publications

Journal Article

  1. Ingalls EM, Veillette JJ, Olson J, May SS, Dustin Waters C, Gelman SS, Vargyas G, Hutton M, Tinker N, Fontaine GV, Foster RA, Stallsmith J, Earl A, Buckel WR, Vento TJ (2023). Impact of a Multifaceted Intervention on Antibiotic Prescribing for Cystitis and Asymptomatic Bacteriuria in 23 Community Hospital Emergency Departments. Hosp Pharm, 58(4), 401-407.
  2. Veillette JJ, Waters CD, Olson J, Vargyas G, Ingalls EM, Hutton MA, Tinker N, May SS, Foster RA, Stallsmith J, Vento TJ (2023). Outcomes of patients with bacteriuria/pyuria of clinically undetermined significance (BPCUS) treated with antibiotics in 23 community hospital emergency departments. Antimicrob Steward Healthc Epidemiol, 3(1), e114.
  3. Gray L, Olson J, Brintz BJ, Cipriano SD (2022). Staphylococcal scalded skin syndrome: Clinical features, ancillary testing, and patient management. Pediatr Dermatol, 39(6), 908-913.
  4. O'Leary EN, Edwards JR, Srinivasan A, Neuhauser MM, Soe MM, Webb AK, Edwards EM, Horbar JD, Soll RF, Roberts J, Hicks LA, Wu H, Zayack D, Braun D, Cali S, Edwards WH, Flannery DD, Fleming-Dutra KE, Guzman-Cottrill JA, Kuzniewicz M, Lee GM, Newland J, Olson J, Puopolo KM, Rogers SP, Schulman J, Septimus E, Pollock DA (2022). National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration Ratios. Hosp Pediatr, 12(2), 190-198.
  5. Olson J, Franz-O'Neal E, Cipriano FA, Ou Z, Presson AP, Thorell EA (2022). Impact of Early Oral Antibiotic Therapy in Infants With Bacteremic Urinary Tract Infections. Hosp Pediatr, 12(7), 632-638.
  6. Franz-O'Neal E, Olson J, Thorell EA, Cipriano FA (2021). Follow-Up Blood Cultures in Young Infants With Bacteremic Urinary Tract Infections.(Epub ahead of print). Hosp Pediatr.
  7. Jones TW, Fino N, Olson J, Hersh AL (2021). The impact of beta-lactam allergy labels on hospitalized children. Infect Control Hosp Epidemiol, 42(3), 318-324.
  8. Olson J, Mehra S, Hersh AL, Thorell EA, Stoddard GJ, Maese L, Barnette PE, Lemons RS, Pavia AT, Knackstedt ED (2021). Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer. J Pediatric Infect Dis Soc, 10(1), 27-33.
  9. Veillette JJ, Waters CD, Gelman SS, Hoopes L, Vargyas G, McKay A, Good T, Olson J, Vento TJ (2021). Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departments. Am J Emerg Med, 40, 1-5.
  10. Lane RD, Olson J, Reeder R, Miller B, Workman JK, Thorell EA, Larsen GY (2020). Antibiotic Timing in Pediatric Septic Shock. Hosp Pediatr, 10(4), 311-317.
  11. Olson J, Hersh AL, Sorensen J, Zobell J, Anderson C, Thorell EA (2020). Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement. J Pediatric Infect Dis Soc, 9(3), 334-341.
  12. Wolsey A, Wilcox RA, Olson JA, Boehme S, Anderson CR (2019). Retrospective comparison of two enoxaparin dosing and monitoring protocols at a pediatric hospital. Am J Health Syst Pharm, 76(11), 815-819.
  13. Anderson CR, Lueckler J, Olson JA (2019). Influencing the timing of parenteral nutrition initiation in the pediatric intensive care unit. Pharm Pract (Granada), 17(2), 1416.
  14. Olson J, Thorell EA, Hersh AL (2019). Evaluation of Discharge Antibiotic Prescribing at a Freestanding Children's Hospital: Opportunities for Stewardship. J Pediatric Infect Dis Soc, 8(6), 563-566.
  15. Stockmann C, Olson J, Rashid J, Lubsch L, Young DC, Hersh AL, Frymoyer A, Ampofo K, Liu X, Wang Y, Sherwin CMT, Zobell JT (2019). An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus. J Clin Pharmacol, 59(2), 198-205.
  16. Krah NM, Olson J, Thorell EA, Esquibel L, Osguthorpe RJ, Pavia AT, Hersh AL (2018). Outpatient Parenteral Antimicrobial Therapy in Young Infants. J Pediatric Infect Dis Soc, 7(2), e40-e42.
  17. Quinn NA, Olson JA, Meier JD, Baskin H, Schunk JE, Thorell EA, Hodo LN (2018). Pediatric lateral neck infections - Computed tomography vs ultrasound on initial evaluation. Int J Pediatr Otorhinolaryngol, 109, 149-153.
  18. Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD (2018). Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children. J Pediatric Infect Dis Soc, 7(4), 338-341.
  19. Hersh AL, Olson J, Stockmann C, Thorell EA, Knackstedt ED, Esquibel L, Sanderson S, Pavia AT (2018). Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy. J Pediatric Infect Dis Soc, 7(2), e34-e36.
  20. Hamdy RF, Hsu AJ, Stockmann C, Olson JA, Bryan M, Hersh AL, Tamma PD, Gerber JS (2017). Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children. Pediatrics, 139(6).
  21. Veesenmeyer AF, Olson JA, Hersh AL, Stockmann C, Korgenski K, Thorell EA, Pavia AT, Blaschke AJ (2016). A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures. Infect Dis Ther, 5(4), 555-570.
  22. Sherwin CM, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG (2014). Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis. J Pharmacokinet Pharmacodyn, 41(1), 71-9.
  23. Ames SG, Workman JK, Olson JA, Korgenski EK, Masotti S, Knackstedt ED, Bratton SL, Larsen G (2017). Infectious Etiologies and Patient Outcomes in Pediatric Septic Shock. Journal of the Pediatric Infectious Diseases Society, 6(1), 80-86.
  24. Grant MJ, Olson J, Gerber (2015). Clinician response time for positive blood culture results in a pediatric ICU. Heart & lung, 44(5), 426-9.
  25. Evans RS, Olson JA, Stenehjem E, Buckel WR, Thorell EA, Howe S, Wu X, Jones PS, Lloyd J (2015). Use of computer decision support in an antimicrobial stewardship program (ASP). Applied clinical informatics, 6(1), 120-35.
  26. Anderson CR, Olson J (2015). Correlation of weight-based i.v. immune globulin doses with changes in serum immunoglobulin G levels. American journal of health-system pharmacy, 72(4), 285-9.
  27. Skarda DE, Schall K, Rollins M, Andrews S, Olson J, Greene T, McFadden M, Thorell EA, Barnhart D, Meyers R, Scaife (2015). A dynamic postoperative protocol provides efficient care for pediatric patients with non-ruptured appendicitis. Journal of pediatric surgery, 50(1), 149-52.
  28. Zobell JT, Epps KL, Young DC, Montague M, Olson J, Ampofo K, Chin MJ, Marshall BC, Dasenbrook (2015). Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatric pulmonology, 50(6), 552-9.
  29. Skarda DE, Schall K, Rollins M, Andrews S, Olson J, Greene T, McFadden M, Thorell EA, Barnhart D, Meyers R, Scaife (2014). Response-based therapy for ruptured appendicitis reduces resource utilization. Journal of pediatric surgery, 49(12), 1726-9.
  30. Yu T, Stockmann C, Healy DP, Olson J, Wead S, Neely AN, Kagan RJ, Spigarelli MG, Sherwin C (2015). Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis. Journal of burn care & research, 36(4), e244-52.
  31. Stockmann C, Sherwin CM, Zobell JT, Lubsch L, Young DC, Olson J, Noyes BE, Ampofo K, Spigarelli M (2013). Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Pharmacotherapy, 33(12), 1288-96.
  32. Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, Olson J, Chatfield B (2011). A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatric pulmonology, 46(10), 987-90.

Review

  1. Burgunder L, Heyrend C, Olson J, Stidham C, Lane RD, Workman JK, Larsen GY (2022). Medication and Fluid Management of Pediatric Sepsis and Septic Shock. [Review]. Paediatr Drugs, 24, (3), 193-205.
  2. Job KM, Olson J, Stockmann C, Constance JE, Enioutina EY, Rower JE, Linakis MW, Balch AH, Yu T, Liu X, Thorell EA, Sherwin CM (2016). Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. [Review]. Expert Rev Anti Infect Ther, 14, (8), 731-46.
  3. Stockmann C, Constance JE, Roberts JK, Olson J, Doby EH, Ampofo K, Stiers J, Spigarelli MG, Sherwin C (2014). Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications. Clinical pharmacokinetics, 53(5), 429-54.
  4. Stockmann C, Spigarelli MG, Campbell SC, Constance JE, Courter JD, Thorell EA, Olson J, Sherwin C (2014). Considerations in the pharmacologic treatment and prevention of neonatal sepsis. Paediatric drugs, 16(1), 67-81.

Other

  1. Alzaidi S, Veillette JJ, May SS, Olson J, Jackson K, Waters CD, Butler AM, Hutton MA, Buckel WR, Webb BJ (2023). Oral ß-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source. Open Forum Infect Dis (11(2), p. ofad657). United States.